Delivery Order SPE2DB22D2206-SPE2DB25FEA93

Award Date 11/1/24
Potential Completion Date 11/25/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,867.18 firm-fixed-price contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through August 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a $30,693.10 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of CABOMETYX 40 MG TABLET 30S. The order is a firm fixed-price contract with a completion date of July 15, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $13,867.18 and a period of performance through September 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 contract is for the supply of CABOMETYX 40 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract has a firm fixed price of $15,346.55 and a period of performance through June 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,908.27 firm-fixed-price contract is for the supply of CABOMETYX 60 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and was awarded on October 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,346.55, is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $15,346.55 and a completion date of July 25, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and valid...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The $30,647.60 firm fixed price contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $14,346.44 firm fixed-price contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a specialty medication, with a performance period through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA93
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The firm-fixed-price contract, valued at $27,734.36, has an ultimate completion date of November 25, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs. These contracts enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/31/25, 9:17 AM